HIV Policy and Advocacy

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

The results: 79% of enrolled participants restarted their antiretroviral therapy within a week of enrolling, and 55% were virally suppressed after six months.

For the first time, the influential annual CROI was going to postpone making its ample data available to the public. But the global HIV community swiftly protested.

Racial and generational equity demand that leaders with “founder’s syndrome” transfer knowledge, relationships, and connections to new leaders in the movement to end HIV.

Raniyah Copeland and Stephaun Wallace explain the mission and context for the Black AIDS Institute’s new Scientific Advisory Committee.

Jan. 28, 2021: COVID-19 information mistrust among Black PLWH; opportunities to intervene prior to deadly drug overdoses; we're unprepared for end-of-life needs for aging PLWH; hospitalization disparities despite universal health care.

When organizations commit to cultural humility at the structural level through organizational accountability, HIV care can be far more responsive, community-focused, and of higher quality.

Dec. 10, 2020: Where the Ending the HIV Epidemic plan falls short; housing instability and HIV care incentives; financial wellbeing vs. health care access; San Diego's complex webs of HIV transmission.

It’s long been time to put Black experts at the center of public health, make public health visible and relatable to people, and truly understand and address medical mistrust.

An important new analysis describes a key barrier to PrEP in the U.S., one that is almost sinister in its application predominantly in southern states.